jap02-14

Embed Size (px)

Citation preview

  • 8/10/2019 jap02-14

    1/5

    Inhibition of HIV-1 reverse transcriptase and HIV-1 integrase and

    antiviral activity of Korean seaweed extracts

    Mi-Jeong Ahn1, Kee-Dong Yoon1, Chul Young Kim1, So-Young Min1, Yong-ung Kim1,

    Hyun Jin Kim2, Jeong Ha Kim2, Cha-Gyun Shin3, Chong-Kyo Lee4, Tae Gyun Kim5,Seung Hee Kim5, Hoon Huh1 and Jinwoong Kim1,*1College of Pharmacy, Seoul National University, Seoul, 151742, Korea; 2Department of Biological Sciences,

    Sungkyunkwan University, Suwon, 440746, Korea; 3Department of Biotechnology, Chung-Ang University,

    Anseong, Kyungki-Do, 456756, Korea; 4Korean Research Institute of Chemical Technology (KRICT), Taejon,

    305600, Korea; 5National Institute of Toxicological Research, Korea Food and Drug Administration, Seoul,

    122-020, Korea; *Author for correspondence (e-mail: [email protected]; fax +82-(2)-8878509)

    Received 12 November 2001; accepted in revised form 19 December 2001

    Key words:Antiviral activity, HIV-1 integrase, HIV-1 reverse transcriptase, Macroalgae, Seaweed extracts

    Abstract

    Forty-seven species of marine macroalgae from the coast of Korea have been screened for the presence of in-

    hibitory compounds against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) and HIV-1

    integrase (IN). One of 4 Chlorophyta, 8 of 17 Phaeophyta and 6 of 26 Rhodophyta showed inhibitory activity

    against HIV-1 reverse transcriptase. Five species (Ecklonia cava,Ishige okamurae,Sargassum confusum,Sar-

    gassum hemiphyllum,Sargassum ringgoldianum) belonging to Phaeophyta showed to inhibit the 3-processing

    activity of HIV-1 integrase. In cell-based assays, the methanol extracts ofBossiellasp. andChondria crassicau-

    lisinhibited cytopathogenecity of HIV-1 at a concentration below that cytotoxic for MT4 cells.

    Abbreviations: CCID50

    50% cell culture inhibitory dose, CHAPS 3-[(3-Cholamidopropyl)dimethylammo-

    nio]-1-propane-sulfonate, DMSO dimethylsulfoxide, IN integrase, MOI multiplicity of infection, MTT 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide, PMSF phenylmethylsulfonyl fluoride, RT re-

    verse transcriptase

    Introduction

    Human immunodeficiency virus type 1 (HIV-1) is the

    cause of acquired immunodeficiency syndrome

    (AIDS) which has been a major human viral disease.

    The development of anti-HIV agents has been con-

    sidered to be one of the most important approaches

    toward effective therapy for AIDS. The three viral

    enzymes encoded by thepolgene of HIV-1 have been

    regarded as the appropriate targets for the antiretrovi-

    ral agents, since these enzymes play key roles in the

    virus replication cycle. HIV-1 reverse transcriptase

    (RT) converts the single-stranded (+) viral RNA ge-

    nome into double-stranded proviral DNA prior to its

    integration into the host genomic DNA (Rey et al.

    1984). HIV-1 integrase (IN) is an enzyme that incor-

    porates the double-stranded DNA product resulting

    from the reverse transcription of viral RNA into a host

    genome (LaFemina et al. 1992; Andrake and Skalka

    1996). These enzymes along with retroviral protease

    are not indigenous to the host and therefore represent

    attractive targets for new anti-HIV agents.

    The aim of this study was to screen a wide range

    of seaweeds harvested in Korea for their ability to in-

    hibit HIV-1 reverse transcriptase and HIV-1 integrase

    and for their antiviral activity.

    325Journal of Applied Phycology 14: 325329, 2002.

    2003Kluwer Academic Publishers. Printed in the Netherlands.

  • 8/10/2019 jap02-14

    2/5

    Materials and methods

    Sampling and extraction

    Seaweed samples were collected from the coasts of

    Korea including Sungsanpo, Wando and Namhaedo

    from January 1999 to June 2000. After cleaning thesurface of thalli with sea water to remove visible epi-

    phytes and dirt, samples were dried at 60C for 12 h

    in an oven, and then ground in a coffee grinder. A

    1020 g sample was used for the extraction process,

    which involved sonication three times with ca. 200

    mL 100% MeOH,filtration and vacuum evaporation.

    The exact mass was determined after complete lyo-

    philization. Stock solutions were prepared in DMSO

    and kept at 4C until appropriate dilutions of solu-

    tion were used in each assay.

    Assay procedures

    The recombinant HIV-1 RT protein and the RT non-

    radioactive assay kit were purchased from Roche Di-

    agnostics GmbH (Mannheim, Germany). Nevirapine,

    a reference compound, (Viramune, Boehringer-In-

    gelheim Pharma KG, Germany) was provided from

    Boehringer-Ingelheim, Korea. A 20 L of the reac-

    tion mixture containing a template-primer hybrid and

    10 M dUTP/dTTP was added to the wells of a

    streptavidine coated microtiter plate which contained

    20 L of 3 concentrated test samples and 4 ng of

    the HIV-1 RT in 20 L lysis buffer. The reaction was

    carried out at 37 C for 1 h and followed by the ad-dition of 200 L anti-digoxigenin-peroxide solution

    and 200 L ABTS substrate solution. The absorbance

    of each well was recorded at 405 nm with the refer-

    ence wavelength, at 490 nm.

    The preparation of recombinant HIV-1 integrase

    and two radiolabeled 20-mer oligonucleotides and the

    standard HIV-1 integrase assay (3- processing assay)

    were performed as described in Kim et al. (1998). A

    standard reaction assay of endonucleolytic activity

    was carried out in the presence of potential inhibitor

    containing 0.1 pmol of duplex oligonucleotide sub-

    strate (K16 (U5-LTR, +strand), 5-[32P]TGTG-

    GAAAATCTCTAGCAGT-3, and K17 (U5-LTR,

    -strand), 5-ACTGCTAGAGATTTTCCACA-3) and

    15 pmol of HIV-1 integrase in 15 mM Tris-HCl (pH

    7.4), 100 mM NaCl, 1 mM MnCl2, 2 mM 2-mercap-

    toethanol, 2.5 mM CHAPS, 0.1 mM EDTA, 0.1 mM

    PMSF, 1% glycerol, and 10 mM imidazole in a total

    volume of 10 L. Reaction mixtures were incubated

    at 33 C for 90 min and stopped by the addition of 4

    L of 95% formamide, 20 mM EDTA, 0.05% bro-

    mophenol blue and 0.05% xylene cyanol FF. The re-

    actions were heated to 90 C for 3 min and electro-

    phoresed on a 20% denaturing polyacrylamide gel.

    Reaction products were visualized by autoradiogra-

    phy of the wet gel. IC50 values were calculated byscanning bands on Kodak-5film (Image Master VDS,

    Pharmacia Biotech.).

    A standard virus-induced cytopathic effect (CPE)

    inhibition assay (Pauwels et al. 1988) was used for

    anti-HIV-1 assays. MT4 cells (provided by Dr. N

    Yamamoto at Tokyo Medical and Dental University,

    Japan) at the log phase were pelleted and infected

    with virus at an multiplicity of infection (MOI) of 100

    CCID50

    per well. The cells were immediately resus-

    pended with RPMI 1640/10% fetal bovine serum at a

    concentration of 106 cells/ml. One hundred micro-li-

    ter of the resuspended cells were dropped into the

    wells of a 96 well plate which initially contained 100l of 2 concentrated test samples. After 5 days of

    incubation at 37 C, the cells were observed micro-

    scopically and quantified using the MTT assay. Cyto-

    toxicity was evaluated based on the viability of mock-

    infected cells, monitored by MTT method. 2,3-

    dideoxycytosine (ddC) (Sigma) and 2,3-

    dideoxyinosine (ddI) (Sigma) were used as reference

    compounds.

    Results

    Inhibition of HIV-1 RT by seaweed extracts

    In an attempt to screen for antiviral activity, we eval-

    uated the effect of the methanol extracts of Korean

    seaweeds on the HIV-1 RT enzyme. Table 1 summa-

    rizes the results of HIV-1 RT inhibition of 47 extracts

    studied. At the concentration of 200 g mL1 of the

    extracts, one (Monostroma grevillei) of 4 Chloro-

    phyta, 8 (Ecklonia cava,Ishige okamurae,Myelophy-

    cus simplex, Padina crassa, Sargassum confusum,

    Sargassum hemiphyllum, Sargassum muticum, Sar-

    gassum thunbergii) of 17 Phaeophyta and 6 (Acroso-

    riumsp.,Dumontia simplex, Gloiopeltis furcata, Hyp-

    nea japonica, Neorhodomela munica, Schizymenia

    dubyi) of 26 Rhodophyta showed inhibitory activity

    against HIV-1 RT. Among these, E. cava, I. okamu-

    rae, S. confusum and S. hemiphyllum which all be-

    long to Phaeophyta were found to inhibit HIV-1 RT

    more potently than other 11 species. In the experi-

    326

  • 8/10/2019 jap02-14

    3/5

  • 8/10/2019 jap02-14

    4/5

    ment using the nonradioactive RT kit, the IC50

    value

    of nevirapine was 0.097 g mL1.

    Inhibition of HIV-1 IN by seaweed extracts

    HIV-1 IN initially removes two nucleotide bases from

    the 3-end of the linear viral DNA (3-processing).Then it cuts the host DNA and transesterifies its 5-

    end to the viral DNAs newly shortened 3-end (inte-

    gration). In this study, radiolabeled oligonucleotides

    were used to measure the inhibitory effects on this

    3-processing activity of HIV-1 IN by the methanol

    extracts of Korean seaweeds.

    Among the macroalgae tested, the methanol ex-

    tracts of only five Phaeophyta species (E. cava, I.

    okamurae,S. confusum, S. hemiphyllum,S. ringgold-

    ianum) showed the inhibition of the 3-processing ac-

    tivity of HIV-1 IN at the concentration of 100

    g mL

    1

    (Table 1).E. cavashowed the strongest in-hibition of the IN activity. The IC50

    value of baica-

    lein, a reference compound, was 1.2 g mL1 in this

    test.

    Antiviral effects

    In a cell-based assay, we measured the ability of the

    test compounds to inhibit the HIV-1-induced cyto-

    pathogenicity in HIV-1 strain IIIBinfected MT4 cells.

    Bossiella sp. and Chondria crassicaulis showed a

    weak prevention of the virus-induced cytopathogenic

    effect at concentrations below that which is cytotoxic

    for MT4 cells (Table 2).

    Discussion

    Recently, inhibitory activities of algal extracts have

    been investigated against major enzymatic mecha-

    nisms of HIV. Scheffler and Krylov (2000) reviewed

    anti-HIV activity of algal extracts and the compounds

    isolated from the algae. Anti-RT compounds includ-

    ing Peyssonol A and KM043 have been reported by

    several researchers (Talpir et al. 1994; Ohta et al.

    1998). However, to our knowledge, this study is the

    first report in screening inhibitory activity of marine

    algae against HIV-1 integrase. For Korean seaweeds,

    there have been a few previous attempts to screen

    potential antiviral activities from the extracts. The in-

    hibitory activity of Korean seaweeds on Tag DNA

    polymerase, which is related to antiviral activity, has

    been evaluated (Jin et al. 1997). Kim et al. (1997) also

    reported the anti-Herpes simplex virus type 1

    (HSV-1) and anti-Sindbis virus (SINV) activities of

    27 Korean seaweeds.

    In this study, E. cavaappeared to be a potent spe-

    cies, which inhibited both the HIV-1 reverse tran-

    scriptase (RT) and integrase (IN). This macroalga has

    also been reported to show inhibitory activity against

    TaqDNA polymerase (Jin et al. 1997). I. okamurae

    andS. confusum, which displayed anti-HIV-1 RT andIN activities, could be another interesting species.

    Kim et al. (1997) reported that I. okamuraeexhibited

    antiviral activity against SINV. The inhibitory effect

    ofS. confusumonTaqDNA polymerase has also been

    identified (Jin et al. 1997). In anti-HIV-1 RT activity

    test with organic fractions of these three species, the

    ethylacetate fractions showed the most potent inhibi-

    tory activity (Table 3). This result suggests that re-

    sponsible compound(s) involved in these activities

    may not be polysaccharides.

    Extracts ofBossiellasp. and Chondria crassicau-

    lis, which lowered virus cytopathogenecity in de no-

    vo-infected MT4 cells, did not inhibit HIV-1 RT or

    IN. Although Codium fragile, Ulva pertusa, Scytoci-

    phon lomentaria, Undaria pinnatifidaand Carpopel-

    tis affnisdid not show the anti-HIV-1 RT or IN ac-

    tivity in this study, the methanol extracts of these

    Table 2. Antiviral activity against HIV-1 by the methanolic ex-

    tracts ofBossiellasp. andChondria crassicaulis.CC50

    means con-

    centration required to reduce the viability of MT4 cells by 50% as

    determined by the MTT method, whereas EC50

    denotes concentra-

    tion required to prevent the cytopathic effect of HIV-1 by 50%. SI

    stands for selective index (EC50/CC

    50).

    Species CC50

    (g mL1) EC50

    (g mL 1) SI

    Bossiella sp. 120.4 49.2 2.5

    Chondria crassicaulis 135.7 19.9 6.8

    ddI > 100 7.15 > 14.0

    ddC 3.54 0.06 61.6

    Table 3. Inhibition of HIV-1 reverse transcriptase (RT) by the or-

    ganic fractions (100 g mL1) of three Korean seaweed extracts.

    +/, + and ++ indicate 5570%, 7085% and 85% inhibition of

    HIV-1 RT, respectively.

    Species CH2Cl

    2 EtOAc BuOH

    Ecklonia cavaKjellman ++ ++ +

    Ishige okamuraeYendo ++ ++ ++Sargassum confusumC. Agardh +/ ++ +/

    328

  • 8/10/2019 jap02-14

    5/5

    seaweeds together withS. thunbergiiwere reported to

    inhibit HSV-1 or SINV (Kim et al. 1997).

    In conclusion, E. cavais one of the most promis-

    ing species due to its inhibitory strength and the avail-

    ability of sampling, and further investigations focus-

    ing on identifying chemical compounds of valuable

    fractions from several potent species, including E.cava, are in progress. The present study provides an

    additional information of inhibitory activities of sea-

    weeds against HIV-1, which can be useful for the

    discovery of natural products for this particular virus.

    Acknowledgements

    We wish to thank S. M. Boo and Y. S. Oh for the

    identification of seaweeds used in this study. This re-

    search was supported by a grant from the Ministry of

    Maritime Affairs & Fisheries of Korea (19980024).

    References

    Andrake M.D. and Skalka A.M. 1996. Retroviral integrase, putting

    the pieces together. J. Biol. Chem. 6: 1963319636.

    Hudson J.B., Kim J.H., Lee M.K., Hong Y.K. and DeWreede R.E.

    1999. Antiviral compounds in Korean seaweeds: Evidence for

    multiple activities. J. Appl. Phycol. 10: 427434.

    Jin H.J., Kim J.H., Sohn C.H., DeWreede R.E., Choi T.J., Towers

    G.H.N. et al. 1997. Inhibition ofTaqDNA polymerase by sea-

    weed extracts from British Columbia, Canada and Korea. J.

    Appl. Phycol. 9: 383388.

    Kim H.J., Woo E.-R., Shin C.-G. and Park H. 1998. A new fla-

    vonol glycoside gallate ester from Acer okamotoannumand its

    inhibitory activity against human immunodeficiency virus-1

    (HIV-1) integrase. J. Nat. Products 61: 145148.

    Kim J.H., Hudson J.B., Huang A.M., Bannister K., Jin H., Choi

    T.J. et al. 1997. Biological activities of seaweed extracts from

    British Columbia, Canada, and Korea. I. Antiviral activity. Can.

    J. Bot. 75: 16561660.

    LaFemina R.L., Schneider C.L., Robbins H.L., Callahan P.L., LeG-

    row K., Roth E. et al. 1992. Requirement of active human im-

    munodeficiency virus type 1 integrase for productive infection

    of human T-lymphoid cells. J. Virol. 66: 74147419.

    Ohta K., Mizushina Y., Hirata N., Takemura M., Sugawara F., Mat-

    sukage A. et al. 1998. Sulfoquinovosyldiacylglycerol, KM043,

    a new potent inhibitor of eukaryotic DNA polymerases and

    HIV-reverse transcriptase type 1 from a marine red algae, Gi-

    gartina tenella. Chem. Pharm. Bull. 46: 684686.

    Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D.,

    Herdewijn P. et al. 1988. Rapid and automated tetrazolium-

    based colorimetric assay for the detection of anti-HIV com-

    pounds. J. Virol. Methods 20: 309321.

    Rey M.A., Spire B., Dormont D., Barre-Sinoussi F., Montagnier L.

    and Chermann J.C. 1984. Characterization of the RNA depen-

    dent DNA polymerase of a new human T lymphotropic retro-

    virus (lymphadenopathy associated virus). Biochem. Biophys.

    Res. Comm. 121: 126133.

    Scheffler D.J. and Krylov V.S. 2000. Anti-HIV activity of extracts

    and compounds from algae and cyanobacteria. Ecotoxicol. En-

    viron. Saf. 45: 208227.

    Talpir R., Rudi A., Kashman Y., Loya Y. and Hizi A. 1994. Three

    new sesquiterpene hydroquinones from marine origin. Tetrahe-

    dron 50: 41794184.

    329